L. C. Afonso, T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri et al., The adjuvant effect of interleukin-12 in a vaccine against Leishmania major, Science, vol.263, pp.235-237, 1994.

W. Al-saleh, S. L. Giannini, N. Jacobs, M. Moutschen, J. Doyen et al., Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix, J. Pathol, vol.184, pp.283-290, 1998.

B. P. Arulanandam, M. O'toole, and D. W. Metzger, Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity, J. Infect. Dis, vol.180, pp.940-994, 1999.

H. Barth, R. Klein, P. A. Berg, B. Wiedenmann, U. Hopf et al., Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B, Hepatogastroenterology, vol.48, pp.553-555, 2001.

L. G. Bermúdez-humarán, P. Langella, A. Miyoshi, A. Gruss, R. S. Tamez-reyes et al., Production of human papillomavirus type 16 E7 protein in Lactococcus lactis, Appl. Environ. Microbiol, vol.68, pp.917-922, 2002.

P. N. Boyaka and J. R. Mcghee, Cytokines as adjuvants for the induction of mucosal immunity, Adv. Drug Deliv. Rev, vol.51, pp.71-79, 2001.

M. Brunda, L. Luistro, R. Warrier, R. Wright, B. Hubbard et al., Antitumor and antimetastatic activity of interleukin 12 against murine tumors, J. Exp. Med, vol.178, pp.1223-1230, 1993.

S. H. Chan, B. Perussia, J. W. Grupta, M. Kobayashi, M. Pospisil et al., Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers, J. Exp. Med, vol.173, pp.869-879, 1991.

B. Chen, T. M. Timiryasova, D. S. Gridley, M. L. Andres, R. Dutta-roy et al., Evaluation of cytokine toxicity induced by vaccinia virusmediated IL-2 and IL-12 antitumour immunotherapy, Cytokine, vol.15, pp.305-334, 2001.

J. Cohen, IL-12 deaths: explanation and a puzzle, Science, vol.270, p.908, 1995.

P. G. De-ruyter, O. P. Kuipers, and W. M. De-vos, Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin, Appl. Environ. Microbiol, vol.62, pp.3662-3667, 1996.

S. Drouault, G. Corthier, S. D. Ehrlich, and P. Renault, Survival, physiology, and lysis of Lactococcus lactis in the digestive tract, Appl. Environ. Microbiol, vol.65, pp.4881-4886, 1999.
URL : https://hal.archives-ouvertes.fr/hal-02697509

V. Enouf, P. Langella, J. Commissaire, J. Cohen, and G. Corthier, Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic, Appl. Environ. Microbiol, vol.67, pp.1423-1428, 2001.
URL : https://hal.archives-ouvertes.fr/hal-02672540

M. J. Gasson, Plasmid complements of Streptococcus lactis NCDO 712 and other lactic acid streptococci after protoplast-induced curing, J. Bacteriol, vol.154, pp.1-9, 1983.

D. Gaucher and K. Chadee, Molecular cloning of gerbil interleukin 12 and its expression as a bioactive single-chain protein, Cytokine, vol.14, pp.177-183, 2001.

M. C. Geoffroy, C. Guyard, B. Quatannens, S. Pavan, M. Lange et al., Use of green fluorescent protein to tag lactic acid bacterium strains under development as live vaccine vectors, Appl. Environ. Microbiol, vol.66, pp.383-391, 2000.

M. M. Gherardi, J. C. Ramirez, and M. Esteban, Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 Env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide, J. Virol, vol.74, pp.6278-6286, 2000.

S. J. Ghim, J. Sundberg, G. Delgado, and A. B. Jenson, The pathogenesis of advanced cervical cancer provides the basis for an empirical therapeutic vaccine, Exp. Mol. Pathol, vol.71, pp.181-185, 2001.

T. J. Gibson, , 1984.

S. Gillessen, D. Carvajal, P. Ling, F. J. Podlaski, D. L. Stremlo et al., Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist, Eur. J. Immunol, vol.25, pp.200-206, 1995.

B. S. Graham, G. S. Henderson, Y. W. Tang, X. Lu, K. M. Neuzil et al., Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus, J. Immunol, vol.151, pp.2032-2040, 1993.

C. Grangette, H. Muller-alouf, M. Geoffroy, D. Goudercourt, M. Turneer et al., Protection against tetanus toxin after intragastic administration of two recombinant lactic acid bacteria: impact of strain variability and in vivo persistence, Vaccine, vol.20, pp.3304-3309, 2002.

U. Gubler, A. O. Chua, D. S. Schoenhaut, C. M. Dwyer, W. Mccomas et al., Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor, Proc. Natl. Acad. Sci. USA, vol.88, pp.4143-4147, 1991.

D. L. Hoover, R. M. Crawford, L. L. Van-de, M. J. Verg, A. K. Izadjoo et al., Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK), Infect. Immun, vol.67, pp.5877-5884, 1999.

O. H. Hultgren, M. Stenson, and A. Tarkowski, Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis, Arthritis Res, vol.3, pp.41-47, 2001.

M. A. Jacobson, D. Hardy, E. Connick, J. Watson, and M. Debruin, Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microl, J. Infect. Dis, vol.182, pp.1070-1076, 2000.

C. Jiang, D. M. Magee, and R. A. Cox, Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis, Infect. Immun, vol.67, pp.2996-3001, 1999.

M. Kobayashi, L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark et al., Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes, J. Exp. Med, vol.170, pp.827-845, 1989.

T. Kokuho, S. Watanabe, Y. Yokomizo, and S. Inumaru, Production of biologically active, heterodimeric porcine interleukin-12 using a monocistronic baculoviral expression system, Vet. Immunol. Immunopathol, vol.72, pp.289-302, 1999.

O. P. Kuipers, P. G. De-ruyter, M. Kleerebezen, and W. M. De-vos, Quorum sensing-controlled gene expression in lactic acid bacteria, J. Biotechnol, vol.64, pp.15-21, 1998.

U. K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, vol.227, pp.680-685, 1970.

P. Langella, Y. L. Loir, S. D. Ehrlich, and A. Gruss, Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis, J. Bacteriol, vol.175, pp.5806-5813, 1993.
URL : https://hal.archives-ouvertes.fr/hal-01123015

M. H. Lee, Y. Roussel, M. Wilks, and S. Tabaqchali, Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice, Vaccine, vol.19, pp.3927-3935, 2001.

S. Lee, M. Zheng, S. Deshpande, S. K. Eo, T. A. Hamilton et al., IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis, J. Leukoc. Biol, vol.71, pp.469-476, 2002.

L. Loir, Y. , A. Gruss, S. D. Ehrlich, and P. Langella, A nine-residue, vol.71, 1998.
URL : https://hal.archives-ouvertes.fr/hal-02687605

, synthetic propeptide enhances secretion efficiency of heterologous proteins in Lactococcus lactis, J. Bacteriol, vol.180, pp.1895-1903

J. P. Leonard, M. L. Sherman, G. L. Fisher, L. J. Buchanan, G. Larsen et al., Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production, Blood, vol.90, pp.2541-2548, 1997.

P. Ling, M. K. Gately, U. Gubler, A. S. Stern, P. Lin et al., Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity, J. Immunol, vol.154, pp.116-127, 1995.

V. W. Lui, L. D. Falo, and L. Huang, Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo, J. Gene Med, vol.3, pp.384-393, 2001.

D. M. Magee and R. A. Cox, Interleukin-12 regulation of host defenses against Coccidioides immitis, Infect. Immun, vol.64, pp.3609-3613, 1996.

G. Mazzolini, I. Narvaiza, A. Perez-diez, M. Rodriguez-calvillo, C. Qian et al., Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12, Gene Ther, vol.8, pp.259-267, 2001.

D. W. Metzger, R. M. Mcnutt, J. T. Collins, J. M. Buchanan, V. H. Van-cleave et al., Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms, Eur. J. Immunol, vol.27, pp.1958-1965, 1997.

N. Michel, W. Osen, L. Gissmann, T. N. Schumacher, H. Zentgraf et al., Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination, Virology, vol.294, pp.47-59, 2002.

C. Nastala, H. Edington, T. Mckinney, H. Tahara, M. Nalesnik et al., Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production, J. Immunol, vol.153, pp.1697-1703, 1994.

S. H. Paik, A. Chakicherla, and J. N. Hansen, Identification and characterization of the structural and transporter genes for, and the chemical and biological properties of, sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168, J. Biol. Chem, vol.273, pp.23134-23142, 1998.

A. Y. Park, B. Hondowicz, M. Kopf, and P. Scott, The role of IL-12 in maintaining resistance to Leishmania major, J. Immunol, vol.168, pp.5771-5777, 2002.

M. S. Payne and E. N. Jackson, Use of alkaline phosphatase fusions to study protein secretion in Bacillus subtilis, J. Bacteriol, vol.173, pp.2278-2282, 1991.

F. J. Podlaski, V. B. Nanduri, J. D. Hulmes, Y. C. Pan, W. Levin et al., Molecular characterization of interleukin 12, Arch. Biochem. Biophys, vol.294, pp.230-237, 1992.

I. Poquet, S. D. Ehrlich, and A. Gruss, An export-specific reporter designed for gram-positive bacteria: application to Lactococcus lactis, J. Bacteriol, vol.180, pp.1904-1912, 1998.
URL : https://hal.archives-ouvertes.fr/hal-02693894

A. L. Rakhmilevich, J. Turner, M. J. Ford, D. Mccabe, W. H. Sun et al., Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established and metastatic murine tumors, Proc. Natl. Acad. Sci. USA, vol.93, pp.6291-6296, 1996.

K. Robinson, L. M. Chamberlain, K. M. Schofield, J. M. Wells, and R. W. , Oral vaccination of mice against tetanus with recombinant Lactococcus lactis, Nat. Biotechnol, vol.15, pp.653-657, 1997.

J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular cloning: a laboratory manual, 1989.

H. Shen, C. Li, M. Lin, Z. Zhang, and Q. Shen, Expression of human interleukin 12 (hIL-12) in insect cells, Chin. J. Biotechnol, vol.14, pp.205-212, 1998.

J. I. Sin, J. J. Kim, R. L. Arnold, K. E. Shroff, D. Mccallus et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4 ? T cell-mediated protective immunity against herpes simplex virus-2 challenge, J. Immunol, vol.162, pp.2912-2921, 1999.

J. G. Sinkovics and J. C. Horvath, Vaccination against human cancers, Int. J. Oncol, vol.16, pp.81-96, 2000.

L. Steidler, K. Robinson, L. Chamberlain, K. M. Schofield, E. Remaut et al., Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine, Infect. Immun, vol.66, pp.3183-3189, 1998.

L. Steidler, W. Hans, L. Schotte, S. Neirynck, F. Obermeier et al., Treatment of murine colitis by Lactococcus lactis secreting interleukin-10, Science, vol.289, pp.1352-1355, 2000.

K. Takehara, T. Nagata, R. Kikura, T. Takanashi, S. Yoshiya et al., Expression of a bioactive interleukin-12 using baculovirus, Vet. Immunol. Immunopathol, vol.77, pp.15-25, 2000.

G. Trinchieri, Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity, Annu. Rev. Immunol, vol.13, pp.251-276, 1995.

M. Van-asseldonk, G. Rutten, M. Oteman, R. J. Siezen, W. M. De-vos et al., Cloning, expression in Escherichia coli and characterization of usp45, a gene encoding a highly secreted protein from Lactococcus lactis MG1363, Gene, vol.95, pp.155-160, 1990.

E. E. Voest, B. M. Kenyon, M. S. O'reilly, G. Truitt, R. J. D'amato et al., Inhibition of angiogenesis in vivo by interleukin 12, J. Natl. Cancer Inst, vol.19, pp.581-586, 1995.

V. L. Wilkinson, R. R. Warrier, T. P. Truitt, P. Nunes, M. K. Gately et al., Characterization of anti-mouse IL-12 monoclonal antibodies and measurement of mouse IL-12 by ELISA, J. Immunol. Methods, vol.189, pp.15-24, 1996.